Workflow
业绩快报
icon
Search documents
湖南华纳大药厂股份有限公司2025年度业绩快报公告
Financial Data Summary - The company reported preliminary financial data for the year 2025, with total revenue of 1.516 billion yuan, representing a year-on-year increase of 7.26% [1] - The net profit attributable to the parent company was 241 million yuan, showing a significant year-on-year growth of 46.95% [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 130 million yuan, which reflects a decrease of 6.01% compared to the previous year [1] - Total assets at the end of the reporting period reached 3.053 billion yuan, marking a year-on-year increase of 24.11% [1] - The equity attributable to the parent company was 2.046 billion yuan, up 13.44% year-on-year [1] Performance Drivers - The increase in revenue was primarily driven by growth in sales of formulation products, raw materials, intermediate products, and technical service income [2] - The rise in net profit attributable to the parent company was mainly influenced by investment income [2] - The decline in net profit after deducting non-recurring gains and losses was attributed to the impact of stock incentive expenses; excluding these expenses, the adjusted net profit would have been 182 million yuan, an increase of 31.57% year-on-year [2] Significant Changes in Financial Metrics - Operating profit increased by 51.53% year-on-year, while total profit rose by 51.88% [3] - The basic earnings per share grew by 47.20% year-on-year, largely due to the strategic investment and restructuring of Shanghai Zhigen Pharmaceutical Technology Co., Ltd., which resulted in the company no longer consolidating it in its financial statements [3] - The company's share capital increased by 40.00% due to a capital reserve conversion, raising the total shares from 93.8 million to 131.32 million [3]
上海汉钟精机股份有限公司 2025年度业绩快报
特别提示: ■ 注:上述数据以公司合并报表数据填列。 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 本公告所载2025年度的财务数据仅为初步核算数据,已经公司内部审计部门审计,未经会计师事务所审 计,与2025年度报告中披露的最终数据可能存在差异,请投资者注意投资风险。 一、2025年度主要财务数据和指标 单位:万元 五、其他说明 不适用。 六、备查文件 1、经公司法定代表人、主管会计工作的负责人、会计机构负责人(会计主管人员)签字并盖章的比较 式资产负债表和利润表。 二、经营业绩和财务状况情况说明 1、报告期内,公司营业收入较上年同期下降20.32%,主要系光伏行业处于深度调整阶段,整体开工率 偏低,终端需求下滑,公司应用于光伏领域的真空泵产品收入相应减少。 2、报告期内,公司归属于上市公司股东的净利润较上年同期下降45.54%,主要系营业收入下降及毛利 率下滑所致。此外,受台币兑美元汇率波动的影响,公司产生相应汇兑损失,进而影响2025年度整体盈 利表现。 三、与前次业绩预计的差异说明 本次业绩快报披露前 ...
上海汉钟精机股份有限公司2025年度业绩快报
Financial Performance Summary - In 2025, the company's operating revenue decreased by 20.32% compared to the previous year, primarily due to the photovoltaic industry undergoing a deep adjustment phase, resulting in low overall operating rates and declining end-user demand, which led to a corresponding decrease in revenue from vacuum pump products used in the photovoltaic sector [2] - The net profit attributable to shareholders of the listed company fell by 45.54% year-on-year, mainly due to the decline in operating revenue and a decrease in gross profit margin. Additionally, the company incurred foreign exchange losses due to fluctuations in the TWD/USD exchange rate, which further impacted the overall profitability for 2025 [2] Performance Forecast Discrepancy - Prior to this performance announcement, the company had not disclosed any forecasts for its 2025 operating performance [3] Other Information - The financial data presented is preliminary and has been audited by the company's internal audit department but has not yet been audited by an external accounting firm, indicating potential discrepancies with the final data to be disclosed in the annual report [1]
影石创新(688775.SH)2025年度归母净利润9.64亿元,同比下降3.08%
智通财经网· 2026-02-13 13:55
Core Viewpoint - Yingstone Innovation (688775.SH) reported a significant increase in total operating revenue for the fiscal year 2025, while net profit experienced a slight decline [1] Group 1: Financial Performance - The total operating revenue for 2025 reached 9.858 billion yuan, representing a year-on-year growth of 76.85% [1] - The net profit attributable to the parent company's shareholders was 964 million yuan, showing a year-on-year decrease of 3.08% [1] Group 2: Factors Influencing Performance - The company has been actively expanding its market presence and launching new products, which significantly contributed to the revenue growth [1] - The company has increased its investment in research and development, focusing on customized chips and strategic projects, with R&D expenditure amounting to 1.649 billion yuan during the reporting period [1]
汉钟精机(002158.SZ)业绩快报:2025年净利润4.7亿元 同比下降45.54%
Ge Long Hui A P P· 2026-02-13 10:32
格隆汇2月13日丨汉钟精机(002158.SZ)公布2025年度业绩快报,营业总收入29.28亿元,同比下降 20.32%,归属于上市公司股东的净利润4.7亿元,同比下降45.54%。报告期内,公司营业收入较上年同 期下降20.32%,主要系光伏行业处于深度调整阶段,整体开工率偏低,终端需求下滑,公司应用于光 伏领域的真空泵产品收入相应减少。报告期内,公司归属于上市公司股东的净利润较上年同期下降 45.54%,主要系营业收入下降及毛利率下滑所致。此外,受台币兑美元汇率波动的影响,公司产生相 应汇兑损失,进而影响2025年度整体盈利表现。 ...
奇正藏药(002287.SZ)业绩快报:2025年净利润6.46亿元 同比增长10.98%
Ge Long Hui A P P· 2026-02-13 08:44
格隆汇2月13日丨奇正藏药(002287.SZ)公布2025年度业绩快报,报告期内,公司实现营业总收入24.16亿 元,较上年同期增长3.34%,归属于上市公司股东的净利润6.46亿元,同比增长10.98%,扣除非经常性 损益后的归属于上市公司股东的净利润4.77亿元,同比增长12.03%。 ...
金橙子:2025年度业绩快报公告
Zheng Quan Ri Bao· 2026-02-12 10:14
证券日报网讯 2月12日,金橙子发布公告称,公司2025年实现营业收入25339.82万元,同比增长 19.46%;归属于母公司所有者的净利润3726.47万元,同比增长22.20%;归属于母公司所有者的扣除非 经常性损益的净利润3061.81万元,同比增长50.74%。 (文章来源:证券日报) ...
金迪克(688670.SH)2025年度归母净亏损1.73亿元
智通财经网· 2026-02-12 08:33
金迪克(688670.SH)披露2025年度业绩快报,公司2025年营业收入1.13亿元,同比增长40.13%;归属于母 公司所有者的净利润亏损1.73亿元,上年同期亏损9350.28万元。 报告期内,营业收入同比增长40.13%,主要系公司提前排产,各部门协调配合,提升生产效率,加快 了流感疫苗生产和批签发节奏,解决出货晚影响发货问题,同时深入客户服务,持续优化营销管理体 系,拓展新的增量市场,提高产品覆盖率。营业利润、利润总额、归属于母公司所有者的净利润、归属 于母公司所有者的扣除非经常性损益的净利润、基本每股收益、加权平均净资产收益率等各项指标在报 告期内变动幅度较大,主要系公司研发投入大幅增加、计提资产减值准备和存货报废等因素影响所致。 ...
长光华芯业绩快报:2025年度归母净利润1952.26万元,同比扭亏
Xin Lang Cai Jing· 2026-02-11 09:53
长光华芯2月11日发布2025年度业绩快报,报告期内实现营业收入4.68亿元,同比增长71.81%;归属于 上市公司股东的净利润1952.26万元,上年同期净利润亏损9973.59万元;基本每股收益0.1107元。 ...
光威复材股东减持完成,2025年业绩快报出炉
Jing Ji Guan Cha Wang· 2026-02-11 06:24
Group 1: Corporate Actions - The company's board member Duan Zhangbing and some senior executives have completed their share reduction plan, selling a total of 70,000 shares at an average price of 39.63 yuan per share, representing a reduction ratio of 0.0085% [2] Group 2: Project Development - The construction of the thermoplastic composite material production line is progressing normally, with specific capacity utilization details to be confirmed after annual settlement [3] Group 3: Financial Performance - For the year 2025, the company reported total revenue of 2.859 billion yuan, an increase of 16.68% year-on-year, while the net profit attributable to shareholders decreased by 18.86% to 601 million yuan [4] Group 4: Business Progress - The company has a presence in the photovoltaic prepreg business, but its contribution to overall revenue is limited; further analysis is needed for details regarding the supply to the aerospace sector in 2025 [5]